XML 16 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (14,845) $ (51,080)  
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 753 1,020  
Non-cash share-based compensation expense 2,048 2,835  
(Gain) loss on disposal of property and equipment (62) 226  
Gain on sale of Freeline Therapeutics GmbH (20,279)    
Gain on legal settlement (2,227)    
Changes in components of operating assets and liabilities      
Prepaids and other current assets (1,354) 1,083  
Other non-current assets   (167)  
Operating lease right of use assets 1,445 4,519  
Accounts payable (593) 3,443  
Accrued expenses and other current liabilities 879 (7,425)  
Operating lease liabilities, net (1,484) 2,343  
Net cash used in operating activities (35,719) (43,203)  
Cash flows from investing activities:      
Purchase of property and equipment (648) (939)  
Proceeds from the sale of equipment 62    
Proceeds from the sale of Freeline Therapeutics GmbH, net of cash transferred with sale of $1,015 24,203    
Net cash provided by (used in) investing activities 23,617 (939)  
Cash flows from financing activities:      
Proceeds from issuance of ordinary shares   27,328  
Proceeds from employee share purchase plan 32 110  
Net cash provided by financing activities 32 27,438  
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,958 (11,072)  
Net decrease in cash, cash equivalents and restricted cash (10,112) (27,776)  
Cash, cash equivalents and restricted cash      
Beginning of period 48,909 119,063 $ 119,063
End of period 38,797 91,287 48,909
Supplemental disclosure of non-cash flow information:      
Commitment shares issued to Lincoln Park Capital Fund, LLC   963  
Reconciliation of cash, cash equivalents and restricted cash      
Cash and cash equivalents 38,797 89,998 47,279
Long-term restricted cash   1,289  
Total cash, cash equivalents and restricted cash $ 38,797 $ 91,287 $ 48,909